Bring on the biosimilars

Michael Eisenstein

Nature, 2019, vol. 569, issue 7755, S2-S3

Abstract: Some of the most effective modern drugs are complex biological molecules. As their patents expire, drug developers are fashioning copycat versions that could make such therapies cheaper and more broadly available.

Keywords: Drug discovery; Therapeutics; Health care; Intellectual-property rights (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-019-01401-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:569:y:2019:i:7755:d:10.1038_d41586-019-01401-5

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-019-01401-5

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().